MediWound Ltd

(NASDAQ:MDWD)

Latest On MediWound Ltd (MDWD):

Date/Time Type Description Signal Details
2023-05-31 22:31 ESTNewsMediWound: With Expenses Covered, Growth Is Within ReachN/A
2023-05-30 17:26 ESTNewsMediWound GAAP EPS of -$0.44 misses by $0.26, revenue of $3.8M misses by $1.35MN/A
2023-05-30 17:26 ESTNewsMediWound Ltd. (MDWD) Q1 2023 Earnings Call TranscriptN/A
2023-05-30 17:26 ESTNewsMediWound slips after Q1 missN/A
2023-05-27 03:57 ESTNewsMediWound Q1 Earnings PreviewN/A
2023-03-16 20:36 ESTNewsMediWound names industry veteran as CFON/A
2023-03-16 20:36 ESTNewsMediWoundEPS of -$1.18, revenue of $11.62M beats by $5.02MN/A
2023-03-16 20:36 ESTNewsMediWound Ltd. (MDWD) Q4 2022 Earnings Call TranscriptN/A
2023-03-15 13:53 ESTNewsMediWound Q4 2022 Earnings PreviewN/A
2023-01-04 21:36 ESTNewsMediWound: Gaining TractionN/A
2022-12-29 20:29 ESTNewsMediWound, Vericel gain on FDA approval of burn therapyN/A
2022-12-23 10:45 ESTNewsMediWound's burn treatment Nexobrid approved in JapanN/A
2022-12-20 15:02 ESTNewsMediWound gets Swiss marketing approval for burns treatment NexoBridN/A
2022-12-06 04:24 ESTNewsMediWound announces 1-for-7 reverse share splitN/A
2022-11-15 21:57 ESTNewsMediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $5.8M beats by $1.2MN/A
2022-11-15 21:57 ESTNewsMediWound Ltd. (MDWD) Q3 2022 Earnings Call TranscriptN/A
2022-11-15 04:52 ESTNewsMediWound Q3 2022 Earnings PreviewN/A
2022-09-22 20:26 ESTNewsMediWound stock slips on ~$30.5M securities offeringsN/A
2022-09-20 19:14 ESTNewsMediWound's NexoBrid for thermal burns in children gets EMA reviewN/A
2022-08-10 02:57 ESTNewsMediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61MN/A
2022-08-10 02:57 ESTNewsMediWound Ltd. (MDWD) CEO Ofer Gonen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 02:57 ESTNewsMediWound Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 05:06 ESTNewsMediWound Q2 Earnings PreviewN/A
2022-08-03 23:17 ESTNewsMediWound refiling for NexoBrid to treat severe thermal burns gets FDA reviewN/A
2022-07-07 15:49 ESTNewsMediWound adds 13% after favorable data for ulcer candidateN/A
2022-06-30 13:41 ESTNewsMediWound taps Tzvi Palash as COON/A
2022-05-17 12:25 ESTNewsMediWound GAAP EPS of -$0.12 misses by $0.01, revenue of $4.4M beats by $0.11MN/A
2022-05-17 12:25 ESTNewsMediWound picks industry veteran for CEO roleN/A
2022-05-17 12:25 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-16 15:11 ESTNewsMediWound Q1 2022 Earnings PreviewN/A
2022-03-17 15:21 ESTNewsMediWound Q4 2021 Earnings PreviewN/A
2022-03-17 15:20 ESTNewsMediWound GAAP EPS of -$0.15 in-line, revenue of $5.49M misses by $0.05MN/A
2022-03-17 15:19 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 14:30 ESTNewsMediWound slumps on pricing $10M stock offeringN/A
2022-03-02 20:11 ESTNewsMediWound slides on proposed stock offeringN/A
2022-02-10 11:47 ESTNewsMediWound wins $9M additional BARDA funding for NexoBridN/A
2022-01-24 07:28 ESTNewsMediWound reports positive results from Phase 2 trial of EscharEx for debridement of chronic woundsN/A
2021-12-20 10:51 ESTNewsMediWound reports positive initial data from Phase 2 EscharEx study in chronic, hard to heal woundsN/A
2021-11-17 00:12 ESTNewsMediWound EPS beats by $0.01, beats on revenueN/A
2021-11-17 00:12 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 04:19 ESTNewsMediWound Q3 2021 Earnings PreviewN/A
2021-10-13 04:34 ESTNewsWarning: MDWD is at high risk of performing badlyN/A
2021-10-06 12:47 ESTNewsMDWD is at high risk of performing badlyN/A
2021-09-27 21:29 ESTNewsWarning: MDWD has been downgraded to Very BearishN/A
2021-09-22 00:18 ESTNewsWarning: MDWD has been downgraded to Very Bearish.N/A
2021-08-11 04:24 ESTNewsMediwound Ltd (MDWD) CEO Sharon Malka on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 07:32 ESTNewsMediWound EPS misses by $0.01, beats on revenueN/A
2021-07-30 17:24 ESTNewsMediWound: Disappointing Thus Far But Still A Strong BuyN/A
2021-07-29 01:24 ESTNewsMediWound: Adjusting My Strategy After NexoBrid CRLN/A
2021-07-21 15:33 ESTNewsMediWound completes enrollment for interim assessment of mid-stage EscharEx studyN/A

About MediWound Ltd (MDWD):

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

See Advanced Chart

General

  • Name MediWound Ltd
  • Symbol MDWD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 75
  • Fiscal Year EndDecember
  • IPO Date2014-03-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.mediwound.com
View More

Valuation

  • Trailing PE 27.07
  • Price/Sales (Trailing 12 Mt.) 7.03
  • Price/Book (Most Recent Quarter) 21.05
  • Enterprise Value Revenue 6.13
  • Enterprise Value EBITDA 15.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.24
  • Next Year EPS Estimate -$0.54
  • Next Quarter EPS Estimate -$0.12
  • Profit Margin -42%
  • Operating Margin -40%
  • Return on Assets -15%
  • Return on Equity -83%
  • Revenue 21.76 million
  • Earnings Per Share $0.24
  • Revenue Per Share $0.8
  • Gross Profit 7.55 million
  • Quarterly Earnings Growth 22.6%
View More

Highlights

  • Market Capitalization 155.8 million
  • EBITDA 8.18 million
  • PE Ratio -9.93
  • PEG Ratio -0.07
  • Analyst Target Price $7.67
  • Book Value Per Share $0.27
View More

Share Statistics

  • Shares Outstanding 27.24 million
  • Shares Float 16.8 million
  • % Held by Insiders 4277%
  • % Held by Institutions 18.85%
  • Shares Short 33009
  • Shares Short Prior Month 21560
  • Short Ratio 0.22
View More

Technicals

  • Beta 1.54
  • 52 Week High $6.07
  • 52 Week Low $1.44
  • 50 Day Moving Average 5.41
  • 200 Day Moving Average 4.22
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

MediWound Ltd (MDWD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

MediWound Ltd (MDWD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.06-$0.1145.45%
2020-09-302020-11-10$6.63 million-$0.07-$0.1027.08%
2020-06-302020-08-06$N/A-$0.11-$0.128.33%
2020-03-312020-05-20$4.44 million-$0.09-$0.1436.84%
2019-12-312020-02-25$5.44 million-$0.13-$0.10-25%
2019-09-302019-11-14$5.14 million-$0.11-$0.1315.38%
2019-06-302019-08-12$20.75 million$0.47-$0.031907.69%
2019-03-312019-05-21$461000-$0.15-$0.14-7.14%
2018-12-312019-03-25$992000$0.22-$0.15244.74%
2018-09-302018-11-13$858000-$0.11-$0.2043.88%
2018-06-302018-08-07$1.03 million-$0.15-$0.2023.47%
2018-03-312018-05-10$520000-$0.17-$0.14-25.93%
2017-12-312018-03-19$530000-$0.08-$0.1854.93%
2017-09-302017-11-16$739000-$0.16-$0.1915.79%
2017-06-302017-08-03$687000-$0.20-$0.20-2.04%
2017-03-312017-05-08$540000-$0.20-$0.17-19.05%
2016-12-312017-02-21$430000-$0.09-$0.2563.71%
2016-09-302016-11-14$518000-$0.26-$0.26-0.97%
2016-06-302016-07-28$356000-$0.34-$0.24-42.68%
2016-03-312016-04-21$254000-$0.17-$0.2429.52%
2015-12-312016-01-25$267000-$0.36-$0.23-54.51%
2015-09-302015-10-27$102000-$0.17-$0.3145.16%
2015-06-302015-08-03$165000-$0.19-$0.2626.92%
2015-03-312015-05-04$67000-$0.30-$0.25-20%
2014-12-312015-02-12$124000-$0.33-$0.26-26.92%
2014-09-302014-11-05$46000-$0.24-$0.240%
2014-06-302014-07-31$39000-$0.28-$0.17-64.71%
2014-03-312014-05-02$50000-$0.05-$0.1770.59%

MediWound Ltd (MDWD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MediWound Ltd (MDWD) Chart:

MediWound Ltd (MDWD) News:

Below you will find a list of latest news for MediWound Ltd (MDWD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MediWound Ltd (MDWD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-18100CALL0 0159.92TRUE00
2025-07-18120CALL0 0147.23TRUE00
2025-07-18130CALL0 0101.04TRUE00
2025-07-18140CALL0 0158.89TRUE00
2025-07-18150CALL0 0144.51TRUE00
2025-07-18163.75CALL0 1116.41TRUE00
2025-07-18170CALL0 0113.87TRUE00
2025-07-18180CALL0 087.1TRUE00
2025-07-18190CALL0 069.78TRUE00
2025-07-18202.49CALL0 758.42FALSE00
2025-07-18210CALL0 080.21FALSE00
2025-07-18220.25CALL0 116119.45FALSE00
2025-07-18230CALL0 0135.32FALSE00
2025-07-18242.4CALL0 101149.66FALSE00
2025-07-18250.1CALL0 5161.11FALSE00
2025-07-18260.4CALL0 20173.2FALSE00
2025-07-18270CALL0 0182.7FALSE00
2025-07-18280.4CALL0 64103.41FALSE00
2025-07-18290.37CALL0 315203.08FALSE00
2025-07-18100PUT0 0343.1FALSE00
2025-07-18120PUT0 0270.99FALSE00
2025-07-18130.1PUT0 2239.29FALSE00
2025-07-18140.1PUT0 1209.65FALSE00
2025-07-18150PUT0 0181.61FALSE00
2025-07-18160PUT0 0154.69FALSE00
2025-07-18170PUT0 054.27FALSE00
2025-07-18180.45PUT0 0108.56FALSE00
2025-07-18190.7PUT0 11535.73FALSE00
2025-07-18201.25PUT0 570.71TRUE00
2025-07-18210PUT0 086.96TRUE00
2025-07-18220PUT0 091.41TRUE00
2025-07-18230PUT0 075.11TRUE00
2025-07-18240PUT0 093.84TRUE00
2025-07-18254.1PUT0 1130.16TRUE00
2025-07-18260PUT0 0120.2TRUE00
2025-07-18270PUT0 0218.97TRUE00
2025-07-18280PUT0 0153.45TRUE00
2025-07-18290PUT0 0131.11TRUE00
2025-08-15100CALL0 0145.69TRUE00
2025-08-15120CALL0 0120.85TRUE00
2025-08-15130CALL0 091.54TRUE00
2025-08-15140CALL0 0110.16TRUE00
2025-08-15150CALL0 097TRUE00
2025-08-15160CALL0 085.2TRUE00
2025-08-15170CALL0 083.04TRUE00
2025-08-15180CALL0 075.36TRUE00
2025-08-15190CALL0 066.78TRUE00
2025-08-15201.4CALL0 161.25FALSE00
2025-08-15211.12CALL1 4462.5FALSE1.120
2025-08-15220.75CALL33 5345.21FALSE00
2025-08-15230.92CALL0 1166.46FALSE00
2025-08-15240CALL0 095FALSE00
2025-08-15250CALL0 0102.24FALSE00
2025-08-15260CALL0 0107.74FALSE00
2025-08-15270CALL0 0102.36FALSE00
2025-08-15280CALL0 0121.41FALSE00
2025-08-15100PUT0 0215.33FALSE00
2025-08-15120PUT0 0171.89FALSE00
2025-08-15130PUT0 0151.92FALSE00
2025-08-15140PUT0 0134.68FALSE00
2025-08-15150PUT0 0118.21FALSE00
2025-08-15160PUT0 093.9FALSE00
2025-08-15170PUT0 086.57FALSE00
2025-08-15180PUT0 077.75FALSE00
2025-08-15190PUT0 069.15FALSE00
2025-08-15200PUT0 058.18TRUE00
2025-08-15212.1PUT5 041.07TRUE2.10
2025-08-15220PUT0 054.65TRUE00
2025-08-15230PUT0 060.54TRUE00
2025-08-15240PUT0 066.32TRUE00
2025-08-15250PUT0 081.3TRUE00
2025-08-15260PUT0 090.95TRUE00
2025-08-15270PUT0 095.22TRUE00
2025-08-15280PUT0 096.14TRUE00
2025-09-1950CALL0 0181.37TRUE00
2025-09-19100CALL0 0101.55TRUE00
2025-09-19110CALL0 0101.35TRUE00
2025-09-19120CALL0 066.27TRUE00
2025-09-19130CALL0 065.49TRUE00
2025-09-19140CALL0 085.77TRUE00
2025-09-19150CALL0 079.65TRUE00
2025-09-19164.5CALL0 4351.34TRUE00
2025-09-19170CALL0 871.88TRUE00
2025-09-19182.78CALL0 4263.11TRUE00
2025-09-19190CALL0 057.03TRUE00
2025-09-19201.92CALL0 5460.37FALSE00
2025-09-19211.47CALL1 8356.1FALSE1.470
2025-09-19221.1CALL32 4954.33FALSE-0.54-0.33
2025-09-19231.22CALL0 1657.33FALSE00
2025-09-19240.7CALL0 168.67FALSE00
2025-09-19250.6CALL0 4069.28FALSE00
2025-09-19260CALL0 1079.81FALSE00
2025-09-19270CALL0 090.8FALSE00
2025-09-19280.8CALL0 2094.25FALSE00
2025-09-19290CALL0 3195.64FALSE00
2025-09-19301.26CALL1 995105.48FALSE0.912.6
2025-09-19310CALL0 0106.86FALSE00
2025-09-19320CALL0 0110.88FALSE00
2025-09-19330CALL0 0113.83FALSE00
2025-09-19340CALL0 0114.78FALSE00
2025-09-19351.01CALL1 304115.81FALSE1.010
2025-09-1950PUT0 0301.92FALSE00
2025-09-19100PUT0 0162.95FALSE00
2025-09-19110PUT0 0146.53FALSE00
2025-09-19120PUT0 2130.21FALSE00
2025-09-19130PUT0 3264.6FALSE00
2025-09-19140PUT0 3102.18FALSE00
2025-09-19150PUT0 054.94FALSE00
2025-09-19160PUT0 280.47FALSE00
2025-09-19170.8PUT0 3472.53FALSE00
2025-09-19181.1PUT0 4039.47FALSE00
2025-09-19190PUT0 456.56FALSE00
2025-09-19200PUT0 053.16TRUE00
2025-09-19210PUT0 050.38TRUE00
2025-09-19220PUT0 051.13TRUE00
2025-09-19230PUT0 053.98TRUE00
2025-09-19240PUT0 065.52TRUE00
2025-09-19250PUT0 061.47TRUE00
2025-09-19260PUT0 065.08TRUE00
2025-09-19270PUT0 075.92TRUE00
2025-09-19280PUT0 080.86TRUE00
2025-09-19290PUT0 085.52TRUE00
2025-09-19300PUT0 076.94TRUE00
2025-09-19310PUT0 092.12TRUE00
2025-09-19320PUT0 096.1TRUE00
2025-09-19330PUT0 088.27TRUE00
2025-09-19340PUT0 099.14TRUE00
2025-09-19350PUT0 0107.06TRUE00
2025-12-1980CALL0 088.39TRUE00
2025-12-1990CALL0 0111.12TRUE00
2025-12-191012.09CALL0 1102.57TRUE00
2025-12-19110CALL0 084.03TRUE00
2025-12-19120CALL0 079.44TRUE00
2025-12-19130CALL0 077.83TRUE00
2025-12-19140CALL0 072.29TRUE00
2025-12-19150CALL0 070.55TRUE00
2025-12-19160CALL0 065.56TRUE00
2025-12-19170CALL0 156.88TRUE00
2025-12-19180CALL0 049.31TRUE00
2025-12-19190CALL0 050.31TRUE00
2025-12-19202.45CALL0 1050.09FALSE00
2025-12-19213.2CALL0 1552.6FALSE00
2025-12-19222.79CALL0 651.81FALSE00
2025-12-19230CALL0 051.1FALSE00
2025-12-19241.15CALL0 455.05FALSE00
2025-12-19250.95CALL0 958.03FALSE00
2025-12-19260CALL0 061.64FALSE00
2025-12-19270CALL0 059.56FALSE00
2025-12-19280.65CALL10 150.36FALSE0.650
2025-12-19290CALL0 049.09FALSE00
2025-12-19300.5CALL0 16364.06FALSE00
2025-12-19310CALL0 071.15FALSE00
2025-12-19320CALL0 078.6FALSE00
2025-12-19330CALL0 077.75FALSE00
2025-12-19340CALL0 483.26FALSE00
2025-12-19350.56CALL0 1085.7FALSE00
2025-12-1980PUT0 0142.29FALSE00
2025-12-1990PUT0 0126.78FALSE00
2025-12-19100PUT0 0114.18FALSE00
2025-12-19110PUT0 0102.81FALSE00
2025-12-19120PUT0 093.26FALSE00
2025-12-19130PUT0 084.31FALSE00
2025-12-19140.65PUT0 277.24FALSE00
2025-12-19150.9PUT0 270.27FALSE00
2025-12-19161.2PUT0 165.11FALSE00
2025-12-19171.3PUT0 361.83FALSE00
2025-12-19181.7PUT0 658.4FALSE00
2025-12-19190PUT0 555.24FALSE00
2025-12-19200PUT0 050.32TRUE00
2025-12-19210PUT0 050.16TRUE00
2025-12-19223.16PUT0 254.73TRUE00
2025-12-19230PUT0 055.17TRUE00
2025-12-19240PUT0 057.36TRUE00
2025-12-19250PUT0 054.74TRUE00
2025-12-19260PUT0 054.48TRUE00
2025-12-19270PUT0 057.15TRUE00
2025-12-19280PUT0 059.53TRUE00
2025-12-19290PUT0 060.34TRUE00
2025-12-19300PUT0 064.86TRUE00
2025-12-19310PUT0 066.57TRUE00
2025-12-19320PUT0 070.85TRUE00
2025-12-19330PUT0 072.24TRUE00
2025-12-19340PUT0 066.85TRUE00
2025-12-19350PUT0 078.92TRUE00

Latest MDWD Trades:

Date Shares Price
Jun 13, 2022 2:52 PM EST200$1.74

MediWound Ltd (MDWD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001946/0001178913-20-001946-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1593984/000000000019006753/0000000000-19-006753-index.htm
2017-02-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221917000257/0000902219-17-000257-index.htm
2017-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221917000560/0000902219-17-000560-index.htm
2018-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221918000039/0000902219-18-000039-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221919000059/0000902219-19-000059-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221920000291/0000902219-20-000291-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221920000393/0000902219-20-000393-index.htm
2017-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000232/0001178913-17-000232-index.htm
2017-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000245/0001178913-17-000245-index.htm
2017-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000255/0001178913-17-000255-index.htm
2017-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000291/0001178913-17-000291-index.htm
2017-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000310/0001178913-17-000310-index.htm
2017-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000371/0001178913-17-000371-index.htm
2017-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000573/0001178913-17-000573-index.htm
2017-02-2120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000577/0001178913-17-000577-index.htm
2017-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001307/0001178913-17-001307-index.htm
2017-05-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001527/0001178913-17-001527-index.htm
2017-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001531/0001178913-17-001531-index.htm
2017-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001883/0001178913-17-001883-index.htm
2017-07-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002090/0001178913-17-002090-index.htm
2017-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002253/0001178913-17-002253-index.htm
2017-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002600/0001178913-17-002600-index.htm
2017-09-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317002608/0001178913-17-002608-index.htm
2017-09-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002630/0001178913-17-002630-index.htm
2017-09-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002691/0001178913-17-002691-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002695/0001178913-17-002695-index.htm
2017-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002697/0001178913-17-002697-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002703/0001178913-17-002703-index.htm
2017-10-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002869/0001178913-17-002869-index.htm
2017-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002900/0001178913-17-002900-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317003131/0001178913-17-003131-index.htm
2017-11-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317003176/0001178913-17-003176-index.htm
2018-01-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000170/0001178913-18-000170-index.htm
2018-01-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000211/0001178913-18-000211-index.htm
2018-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000314/0001178913-18-000314-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000365/0001178913-18-000365-index.htm
2018-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000428/0001178913-18-000428-index.htm
2018-02-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000676/0001178913-18-000676-index.htm
2018-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000885/0001178913-18-000885-index.htm
2018-03-1920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000887/0001178913-18-000887-index.htm
2018-03-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000892/0001178913-18-000892-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001565/0001178913-18-001565-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001584/0001178913-18-001584-index.htm
2018-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001883/0001178913-18-001883-index.htm
2018-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001923/0001178913-18-001923-index.htm
2018-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001929/0001178913-18-001929-index.htm
2018-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002304/0001178913-18-002304-index.htm
2018-09-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002568/0001178913-18-002568-index.htm
2018-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002903/0001178913-18-002903-index.htm
2019-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000121/0001178913-19-000121-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000309/0001178913-19-000309-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000381/0001178913-19-000381-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000454/0001178913-19-000454-index.htm
2019-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000792/0001178913-19-000792-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000909/0001178913-19-000909-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000911/0001178913-19-000911-index.htm
2019-03-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/0001178913-19-000913-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000920/0001178913-19-000920-index.htm
2019-03-25F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000922/0001178913-19-000922-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000924/0001178913-19-000924-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1593984/000117891319001120/0001178913-19-001120-index.htm
2019-04-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1593984/000117891319001183/0001178913-19-001183-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001289/0001178913-19-001289-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001363/0001178913-19-001363-index.htm
2019-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001559/0001178913-19-001559-index.htm
2019-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001605/0001178913-19-001605-index.htm
2019-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001690/0001178913-19-001690-index.htm
2019-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001934/0001178913-19-001934-index.htm
2019-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002149/0001178913-19-002149-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002192/0001178913-19-002192-index.htm
2019-08-236-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002251/0001178913-19-002251-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002438/0001178913-19-002438-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002449/0001178913-19-002449-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002453/0001178913-19-002453-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002734/0001178913-19-002734-index.htm
2019-12-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002874/0001178913-19-002874-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000022/0001178913-20-000022-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000279/0001178913-20-000279-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000291/0001178913-20-000291-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000638/0001178913-20-000638-index.htm
2020-02-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/0001178913-20-000640-index.htm
2020-02-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000647/0001178913-20-000647-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000649/0001178913-20-000649-index.htm
2020-02-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000651/0001178913-20-000651-index.htm
2020-03-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000684/0001178913-20-000684-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000956/0001178913-20-000956-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001215/0001178913-20-001215-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001535/0001178913-20-001535-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001551/0001178913-20-001551-index.htm
2020-06-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001896/0001178913-20-001896-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001946/0001178913-20-001946-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002286/0001178913-20-002286-index.htm
2020-08-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002493/0001178913-20-002493-index.htm
2020-09-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002640/0001178913-20-002640-index.htm
2020-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002913/0001178913-20-002913-index.htm
2020-10-306-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002949/0001178913-20-002949-index.htm
2017-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312517043820/0001193125-17-043820-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312518045765/0001193125-18-045765-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312519039173/0001193125-19-039173-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000121390019002073/0001213900-19-002073-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000121390020001894/0001213900-20-001894-index.htm
2019-04-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1593984/999999999519000785/9999999995-19-000785-index.htm
2017-02-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999717001269/9999999997-17-001269-index.htm
2017-03-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999717003766/9999999997-17-003766-index.htm
2019-04-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999719002564/9999999997-19-002564-index.htm